Loading...
Beijing Tong Ren Tang Chinese Medicine Company Limited
3613.HK•HKSE
Healthcare
Medical - Pharmaceuticals
HK$7.74
HK$-0.02(-0.26%)
Hong Kong Market opens in 63h 59mBeijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) AI-Powered Stock Analysis
See how Beijing Tong Ren Tang Chinese Medicine Company Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerBeijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) Stock Overall Grade
Beijing Tong Ren Tang Chinese Medicine Company Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Beijing Tong Ren Tang Chinese Medicine Company Limited's overall stock rating.
Forecast
C+Score
59/100Financial Growth
C+Score
50/100Fundamental Growth
B+Score
74/100Key Ratios
A+Score
90/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
94/100Analyst Consensus
C+Score
50/100Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 59/100 (C+), reflecting weak confidence in its potential. Financial Growth (50/100, C+) and Fundamental Growth (74/100, B+) highlight its stability, while Key Ratios (90/100, A+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (94/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Beijing Tong Ren Tang Chinese Medicine Company Limited stock grade, including financials, comparisons, and forecasts.